Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide
M Kanter, M Sapmaz-Metin, B Serez - Archives of gynecology and …, 2016 - Springer
Purpose There is a controversy whether GnRH agonist can reduce the deleterious effects of
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide
M Kanter, M Sapmaz-Metin… - Archives of gynecology …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose There is a controversy whether GnRH agonist can reduce the deleterious effects of
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide
M Kanter, M Sapmaz-Metin… - Archives of Gynecology …, 2016 - search.proquest.com
Purpose There is a controversy whether GnRH agonist can reduce the deleterious effects of
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide
M Kanter, M Sapmaz-Metin, B Serez - Archives of Gynecology and …, 2016 - infona.pl
Purpose There is a controversy whether GnRH agonist can reduce the deleterious effects of
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide
M Kanter, M Sapmaz-Metin, B Serez - Archives of Gynecology and …, 2016 - hero.epa.gov
There is a controversy whether GnRH agonist can reduce the deleterious effects of
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
[引用][C] Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide
M Kanter, M Sapmaz-Metin, B Serez - 2016 - aperta.ulakbim.gov.tr
There is a controversy whether GnRH agonist can reduce the deleterious effects of
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide.
M Kanter, M Sapmaz-Metin, B Serez - Archives of Gynecology and …, 2015 - europepmc.org
Purpose There is a controversy whether GnRH agonist can reduce the deleterious effects of
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide
M Kanter, M Sapmaz-Metin, B Serez - Archives of Gynecology and …, 2016 - infona.pl
Purpose There is a controversy whether GnRH agonist can reduce the deleterious effects of
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
[引用][C] Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide
M Kanter, M Sapmaz-Metin, B Serez - 2016 - aperta.ulakbim.gov.tr
There is a controversy whether GnRH agonist can reduce the deleterious effects of
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …
chemotherapy to prevent ovarian failure. We aimed to examine the possible protective …